Category stocks

Is Pfizer a Buy, Sell, or Hold in 2026?

A few years ago, Pfizer (NYSE: PFE) looked unstoppable. The company generated more than $100 billion in annual revenue early in the pandemic, powered by its COVID-19 vaccine and antiviral treatment Investors piled into the stock, expecting the pharmaceutical giant t